Rossi Lara, Challen Grant A, Sirin Olga, Lin Karen Kuan-Yin, Goodell Margaret A
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
Methods Mol Biol. 2011;750:47-59. doi: 10.1007/978-1-61779-145-1_3.
Hematopoietic stem cells (HSCs) are defined by the capabilities of multi-lineage differentiation and long-term self-renewal. Both these characteristics contribute to maintain the homeostasis of the system and allow the restoration of hematopoiesis after insults, such as infections or therapeutic ablation. Reconstitution after lethal irradiation strictly depends on a third, fundamental property of HSCs: the capability to migrate under the influence of specific chemokines. Directed by a chemotactic compass, after transplant HSCs find their way to the bone marrow, where they eventually home and engraft. HSCs represent a rare population that primarily resides in the bone marrow with an estimated frequency of 0.01% of total nucleated cells. Separating HSCs from differentiated cells that reside in the bone marrow has been the focus of intense investigation for years. In this chapter, we will describe in detail the strategy routinely used by our laboratory to purify murine HSCs, by exploiting their antigenic phenotype (KSL), combined with the physiological capability to efficiently efflux the vital dye Hoechst 33342, generating the so-called Side Population, or SP.
造血干细胞(HSCs)是由多谱系分化能力和长期自我更新能力所定义的。这两种特性都有助于维持系统的稳态,并在遭受感染或治疗性消融等损伤后实现造血功能的恢复。致死性照射后的重建严格依赖于造血干细胞的第三个基本特性:在特定趋化因子影响下迁移的能力。在趋化罗盘的引导下,移植后的造血干细胞找到通往骨髓的路径,最终在骨髓中归巢并植入。造血干细胞是一种罕见的细胞群体,主要存在于骨髓中,估计占总核细胞的0.01%。多年来,将造血干细胞与骨髓中分化的细胞分离一直是深入研究的重点。在本章中,我们将详细描述我们实验室常规使用的纯化小鼠造血干细胞的策略,即利用其抗原表型(KSL),结合有效外排活性染料Hoechst 33342的生理能力,产生所谓的侧群细胞(SP)。